NEXGEL (NXGL) Competitors $2.80 -0.03 (-1.20%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. NSPR, SRTS, MLSS, ZYXI, CTSO, ICCM, VANI, INO, NTRB, and GUTSShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include InspireMD (NSPR), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Zynex (ZYXI), Cytosorbents (CTSO), IceCure Medical (ICCM), Vivani Medical (VANI), Inovio Pharmaceuticals (INO), Nutriband (NTRB), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. NEXGEL vs. InspireMD Sensus Healthcare Milestone Scientific Zynex Cytosorbents IceCure Medical Vivani Medical Inovio Pharmaceuticals Nutriband Fractyl Health NEXGEL (NASDAQ:NXGL) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership. Does the MarketBeat Community believe in NXGL or NSPR? InspireMD received 3 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 4.12% of users gave InspireMD an outperform vote. CompanyUnderperformOutperformNEXGELOutperform Votes150.00% Underperform Votes150.00% InspireMDOutperform Votes44.12%Underperform Votes9395.88% Does the media refer more to NXGL or NSPR? In the previous week, NEXGEL had 1 more articles in the media than InspireMD. MarketBeat recorded 2 mentions for NEXGEL and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.59 beat NEXGEL's score of -1.00 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment NEXGEL Negative InspireMD Positive Which has more risk & volatility, NXGL or NSPR? NEXGEL has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Do insiders and institutionals have more ownership in NXGL or NSPR? 2.2% of NEXGEL shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 24.9% of NEXGEL shares are owned by company insiders. Comparatively, 29.7% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has stronger earnings and valuation, NXGL or NSPR? NEXGEL has higher revenue and earnings than InspireMD. NEXGEL is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$8.69M2.49-$3.16M-$0.50-5.66InspireMD$7.01M10.97-$19.92M-$0.78-3.32 Do analysts rate NXGL or NSPR? InspireMD has a consensus price target of $4.75, indicating a potential upside of 83.40%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NXGL or NSPR more profitable? NEXGEL has a net margin of -52.60% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets NEXGEL-52.60% -71.19% -34.79% InspireMD -413.96%-69.42%-57.68% SummaryInspireMD beats NEXGEL on 11 of the 18 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.66M$4.04B$5.30B$7.35BDividend YieldN/A39.51%5.12%4.30%P/E Ratio-4.8827.6821.8017.80Price / Sales2.4947.06379.9697.74Price / CashN/A51.0838.2634.64Price / Book3.145.816.443.98Net Income-$3.16M$67.09M$3.21B$247.73M7 Day Performance11.42%1.97%2.87%1.81%1 Month Performance-0.35%-4.84%-8.63%-6.98%1 Year Performance28.34%14.47%11.46%1.37% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.4319 of 5 stars$2.83flatN/A+26.3%$21.66M$8.69M-4.8810Short Interest ↑Gap DownNSPRInspireMD2.2861 of 5 stars$2.59-1.9%$4.75+83.4%+17.2%$76.90M$7.01M-3.4550SRTSSensus Healthcare2.4942 of 5 stars$4.48+0.4%$13.00+190.2%+41.2%$73.90M$41.81M11.2040Gap DownMLSSMilestone Scientific2.0355 of 5 stars$0.89+2.3%$1.25+40.4%+58.0%$69.32M$8.88M-12.7130Analyst ForecastNews CoverageGap DownZYXIZynex3.0388 of 5 stars$2.16flat$10.25+374.5%-81.9%$65.29M$192.35M14.40770Analyst ForecastGap DownHigh Trading VolumeCTSOCytosorbents1.7749 of 5 stars$0.99+2.1%$4.67+371.1%+30.4%$61.91M$35.59M-2.75220Gap DownICCMIceCure Medical1.6153 of 5 stars$1.11-2.6%$2.50+125.2%-12.8%$61.61M$3.29M-3.8360Negative NewsVANIVivani Medical2.815 of 5 stars$1.02+6.3%$4.00+292.2%-42.4%$60.42MN/A-2.2720Analyst ForecastShort Interest ↑Gap UpINOInovio Pharmaceuticals3.263 of 5 stars$1.58+1.3%$12.20+672.2%-84.3%$57.93M$217,756.00-0.40320Analyst UpgradeShort Interest ↑High Trading VolumeNTRBNutriband2.8969 of 5 stars$5.09-5.7%$13.00+155.4%+18.0%$56.53M$2.02M-7.1710Gap DownGUTSFractyl Health1.891 of 5 stars$1.07-4.5%$10.00+834.6%-81.6%$54.79M$93,000.00-0.09102Analyst ForecastNews CoverageHigh Trading Volume Related Companies and Tools Related Companies NSPR Alternatives SRTS Alternatives MLSS Alternatives ZYXI Alternatives CTSO Alternatives ICCM Alternatives VANI Alternatives INO Alternatives NTRB Alternatives GUTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXGL Stock Free NXGL Stock Alerts